Laboratory based surveillance of travel-related Shigella sonnei and Shigella flexneri in Alberta from 2002 to 2007

Globalization and Health

Volumn 6, Issue , 2010, Pages

  Drews, Steven J ^a,b   Lau, Chris ^b   Andersen, Marnie ^a   Ferrato, Christina ^a,b   Simmonds, Kim ^c   Stafford, Liala ^a   Fisher, Bev ^a   Everett, Doug ^c   Louie, Marie ^a,b  

^a PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c Alberta Health and Wellness   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZITHROMYCIN; CEFOXITIN; CEFTIOFUR; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIUM; DEVELOPING WORLD; DIARRHEAL DISEASE; DISEASE SPREAD; EPIDEMIOLOGY; GEOGRAPHICAL REGION; GLOBAL PERSPECTIVE; HEALTH RISK; INFECTIVITY; LABORATORY METHOD; PUBLIC HEALTH; SOCIOECONOMIC STATUS; SPECIMEN BANK; TRAVEL BEHAVIOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CANADA; CENTRAL AMERICA; DEVELOPING COUNTRY; EMPORIATRICS; FECES; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; INDIA; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; NORTH AMERICA; PRIORITY JOURNAL; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS;

ALBERTA; CANADA; UNITED STATES;

SHIGELLA; SHIGELLA FLEXNERI; SHIGELLA SONNEI;

EID: 78549239485     PISSN: 17448603     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8603-6-20     Document Type: Article

References (24)

1. Demczuk W, Ng LK, Woodward D, Ahmed R, Clark C, Tabor H, Dore K, Ciampa N, Muckle A. Laboratory Surveillance Data for Enteric Pathogens in Canada: Annual Summary 2006. 2007, Winnipeg, Manitoba, Canada: Public Health Agency of Canada, National Microbiology Laboratory.
2. Centers for Disease Control and Prevention Shigella Surveillance: Annual Summary, 2004. 2005, Atlanta, Georgia, USA: US Department of Health and Human Services, Centers for Disease Control and Prevention.
3. Centers for Disease Control and Prevention National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2004. 2007, Atlanta, Georgia, USA: U.S. Department of Health and Human Services, CDC, Centers for Disease Control and Prevention.
4. Izumiya H, Tada Y, Ito K, Morita-Ishihara T, Ohnishi M, Terajima J, Watanabe H. Characterization of Shigella sonnei isolates from travel-associated cases in Japan. J Med Microbiol 2009, 58:1486-1491. 10.1099/jmm.0.011809-0, 19589900.
5. Gaynor K, Park SY, Kanenaka R, Colindres R, Mintz E, Ram PK, Kitsutani P, Nakata M, Wedel S, Boxrud D, Jennings D, Yoshida H, Tosaka N, He H, Ching-Lee M, Effler PV. International foodborne outbreak of Shigella sonnei infection in airline passengers. Epidemiol Infect 2009, 137:335-341. 10.1017/S0950268807000064, 18177516.
6. Simonsen J, Frisch M, Ethelberg S. Socioeconomic risk factors for bacterial gastrointestinal infections. Epidemiology 2008, 19:282-290. 10.1097/EDE.0b013e3181633c19, 18300694.
7. Todd EC, Greig JD, Bartleson CA, Michaels BS. Outbreaks where food workers have been implicated in the spread of foodborne disease. Part 4. Infective doses and pathogen carriage. J Food Prot 2008, 71:2339-2373.
8. Niyogi SK. Increasing antimicrobial resistance-an emerging problem in the treatment of shigellosis. Clin Microbiol Infect 2007, 13:1141-1143. 10.1111/j.1469-0691.2007.01829.x, 17953700.
9. Nelson JD, Kusmiesz H, Jackson LH, Woodman E. Trimethoprim-sulfamethoxazole therapy for shigellosis. JAMA 1976, 235:1239-1243. 10.1001/jama.235.12.1239, 765518.
10. Vrints M, Mairiaux E, Van ME, Collard JM, Bertrand S. Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. J Clin Microbiol 2009, 47:1379-1385. 10.1128/JCM.02460-08, 2681836, 19321731.
11. Vinh H, Nhu NT, Nga TV, Duy PT, Campbell JI, Hoang NV, Boni MF, My PV, Parry C, Nga TT, Van Minh P, Thuy CT, Diep TS, Phuong le T, Chinh MT, Loan HT, Tham NT, Lanh MN, Mong BL, Anh VT, Bay PV, Chau NV, Farrar J, Baker S. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis 2009, 9:204. 10.1186/1471-2334-9-204, 2803792, 20003464.
12. Haukka K, Siitonen A. Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers. Epidemiol Infect 2008, 136:476-482. 10.1017/S0950268807008862, 2870835, 17578602.
13. Srinivasa H, Baijayanti M, Raksha Y. Magnitude of drug resistant Shigellosis: a report from Bangalore. Indian J Med Microbiol 2009, 27:358-360. 10.4103/0255-0857.55460, 19736408.
14. American Society for Microbiology Manual of Clinical Microbiology. 2003, Washington, DC: American Society for Microbiology, 8, American Society for Microbiology.
15. Ahmed SF, Riddle MS, Wierzba TF, Messih IA, Monteville MR, Sanders JW, Klena JD. Epidemiology and genetic characterization of Shigella flexneri strains isolated from three paediatric populations in Egypt (2000-2004). Epidemiol Infect 2006, 134:1237-1248. 10.1017/S095026880600642X, 2870525, 16690004.
16. Clinical and Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard. 2006, Wayne, Pennsylvania, USA: Clinical and Laboratory Standards Institute, 7, Clinical and Laboratory Standards Institute.
17. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; 17th Informational Supplement. 2007, Wayne, Pennsylvania, USA: Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute.
18. Sanford Guide to Antimicrobial Therapy 2000. 2000, Hyde Park, VT: Antimicrobial Therapy Inc, 30.
19. Sanford Guide to Antimicrobial Therapy 2009. 2009, Sperryville, VT: Antimicrobial Therapy Inc, 39.
20. Rahman M, Shoma S, Rashid H, El AS, Baqui AH, Siddique AK, Nair GB, Sack DA. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J Health Popul Nutr 2007, 25:158-167. 2753991, 17985817.
21. Mensa L, Marco F, Vila J, Gascon J, Ruiz J. Quinolone resistance among Shigella spp. isolated from travellers returning from India. Clin Microbiol Infect 2008, 14:279-281. 10.1111/j.1469-0691.2007.01903.x, 18076667.
22. Pu XY, Pan JC, Wang HQ, Zhang W, Huang ZC, Gu YM. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J Antimicrob Chemother 2009, 63:917-920. 10.1093/jac/dkp087, 19297378.
23. Dutta S, Rajendran K, Roy S, Chatterjee A, Dutta P, Nair GB, Bhattacharya SK, Yoshida SI. Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of Shigellae strains isolated from Kolkata, India during 1995-2000. Epidemiol Infect 2002, 129:235-243. 10.1017/S0950268802007240, 2869882, 12403099.
24. Pazhani GP, Niyogi SK, Singh AK, Sen B, Taneja N, Kundu M, Yamasaki S, Ramamurthy T. Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India. J Med Microbiol 2008, 57:856-863. 10.1099/jmm.0.2008/000521-0, 18566144.